307750 — Kukjeon Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Market Cap
KR₩178bn
Enterprise Value
KR₩197bn
Revenue
KR₩136bn

Annual balance sheet for Kukjeon Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	9,959	39,259	94,971	64,833	46,824
Net Total Accounts Receivable
Net Total Receivables	16,299	20,409	23,919	29,101	29,475
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	39,004	76,915	142,893	123,992	105,189
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	14,473	24,026	46,118	86,060	87,360
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	57,802	106,989	196,097	225,102	212,273
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	21,782	21,852	70,691	99,823	88,576
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	25,572	23,838	104,500	128,681	114,853
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	32,230	83,150	91,597	96,422	97,420
Total Liabilities & Shareholders' Equity	57,802	106,989	196,097	225,102	212,273
Total Common Shares Outstanding